COVID-19 test used by Congress prone to false negatives: FDA
After the Food and Drug Administration issued a warning on Monday that COVID-19 tests produced by the company Curative carry the risk of "false negative results," attending physician of the U.S. Congress Dr. Brian Monahan sent a memo notifying Capitol Hill employees that the Capitol's testing system uses Curative tests.
In the Jan. 4 memo obtained by ABC News, Monahan described the Curative test as "the most accurate available" according to information he'd received to date and noted that the risk of a false negative "is a problem for all coronavirus tests."
"The FDA notice does not raise any doubts about the accuracy of a positive test result," Monahan added. "We expect to have additional information in the coming days from the FDA and our expert consultants with regard to any concerns about the ongoing use of this test for the Capitol community."
-ABC News' Mariam Khan and Anne Flaherty contributed to this report.